Imagen de Portada

Sodium‐Glucose Cotransporter 2 Inhibitors for Metabolic Dysfunction‐Associated Steatohepatitis

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Jiayang Lin, Yan Huang, Bingyan Xu, Chensihan Huang, Fei Teng, Youwen Yuan, Jinhua Zhang, Huijie Zhang
Formato:	Artículo Open Access
Publicado:	Wiley 2026
Materias:	Journal of Diabetes
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Association Between Sodium–Glucose Cotransporter‐2 Inhibitors and Sepsis Risk in Patients With Type 2 Diabetes Mellitus
por: Chun-Ying Wu, et al.
Publicado: (2026)

Correction to “Association Between Sodium–Glucose Cotransporter‐2 Inhibitors and Sepsis Risk in Patients With Type 2 Diabetes Mellitus”
Publicado: (2026)

Gender Bias in Clinical Trials of Sodium–Glucose Cotransporter 2 Inhibitors for the Treatment of Type 2 Diabetes Mellitus: A Systematic Review
por: Santiago José Lora-Escobar, et al.
Publicado: (2025)

Blood Pressure Status Modulates the Therapeutic Response to Sodium‐Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial
por: Ryoichi Ishibashi, et al.
Publicado: (2025)

Renal Protection at a Metabolic Cost: A Systematic Review and Meta‐Analysis of Perioperative Use of Sodium–Glucose Cotransporter 2 Inhibitors
por: Elsayed Balbaa, et al.
Publicado: (2026)

Kidney Effects of Finerenone Added to Sodium‐Glucose Cotransporter 2 Inhibitors in Patients With Diabetic Kidney Disease
por: Qing Yang, et al.
Publicado: (2026)

Cardiovascular Disease Risk Prediction in Patients With Metabolic Dysfunction‐Associated Steatohepatitis
por: Joe Hollinghurst, et al.
Publicado: (2026)

Current Progress and Challenges in the Development of Pharmacotherapy for Metabolic Dysfunction‐Associated Steatohepatitis
por: Yang Zhi, et al.
Publicado: (2024)

Secondary Erythrocytosis Among Type 2 Diabetes Mellitus Patients With Hypogonadism Using Sodium‐Glucose Cotransporter 2 Inhibitors and Testosterone Replacement Therapy
por: Maharan Kabha, et al.
Publicado: (2025)

High Prevalence of Metabolic Dysfunction–Associated Steatohepatitis With Significant Fibrosis in Primary Care and Endocrinology Clinics
por: Srilaxmi Kalavalapalli, et al.
Publicado: (2026)

Cardiorenal Outcomes of Sodium–Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes Mellitus With Nephrotic‐Range Proteinuria: A Multi‐Institutional Target Trial Emulation
por: Jia‐Jin Chen, et al.
Publicado: (2026)

Nocturnal Light Pollution Synergistically Impairs Glucose Metabolism With Age and Weight in Monkeys
por: Shuxing Wang, et al.
Publicado: (2024)

Comparative Efficacy and Safety of Resmetirom and Efruxifermin for Metabolic Dysfunction‐Associated Steatohepatitis: A Network Meta‐Analysis of Randomized Controlled Trials
por: Doha Jaber, et al.
Publicado: (2026)

Association of Monocyte‐to‐HDL Cholesterol Ratio with Endothelial Dysfunction in Patients with Type 2 Diabetes
por: Huihui Zhang, et al.
Publicado: (2024)

Comparison of Sodium‐Glucose Cotransporter 2 Inhibitors Versus Glucagon‐Like Peptide‐1 Receptor Agonists and Risks of Osteoarthritis and Arthroplasty in Patients With Type 2 Diabetes Mellitus: A Propensity Score‐Matched Cohorts Retrospective Study
por: Yu‐Chi Su, et al.
Publicado: (2025)

Expression profile of circular RNAs in type 2 diabetes mellitus patients with retinopathy
por: Wencheng An, et al.
Publicado: (2026)

Insulin or Dapagliflozin Potentially Improves Microcirculatory Dysfunction or INOCA Related to Culprit Vessels in Diabetic Patients With STEMI After DCB Therapy During Long‐Term Follow‐Up
por: Wei You, et al.
Publicado: (2026)

Association of Different Types of Diabetic Autonomic Neuropathy With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes: A Cross‐Sectional Study
por: Ruixue Feng, et al.
Publicado: (2025)

A Single Non‐Invasive Test Cut‐Off Should Not Serve Three Distinct Clinical Purposes in Metabolic Dysfunction‐Associated Steatotic Liver Disease and Steatohepatitis
por: Gong Feng, et al.
Publicado: (2026)

Predictive Capability of Dual Trajectories of Central Adiposity Indices Combined With Glucose for Cardiovascular Diseases
por: Gangjiao Zhu, et al.
Publicado: (2025)

Corrigendum to “Nocturnal Light Pollution Synergistically Impairs Glucose Metabolism With Age and Weight in Monkeys”
Publicado: (2025)

Does Metabolic Status Associate With IVF Outcomes in Women Within Similar Body Mass Index Category: Evidence From a Large Cohort Study
por: Lin Ding, et al.
Publicado: (2025)

Association between obstructive sleep apnea syndrome and type1/type2 diabetes mellitus: A systematic review and meta‐analysis
por: Huiling Huang, et al.
Publicado: (2024)

Assessing the Association Between T2DM, Rheumatoid Arthritis, and Dipeptidyl Peptidase‐4 Inhibitors: Insights From Epidemiology, Meta‐Analysis, and Mendelian Randomization Study
por: Lirong Zhang, et al.
Publicado: (2026)

RETRACTION: Quercetin Improves Glucose and Lipid Metabolism of Diabetic Rats: Involvement of Akt Signaling and SIRT1
por: Journal of Diabetes Research
Publicado: (2026)

Glucose‐Responsive PEGDA‐GelMA‐MPBA Hydrogel Loaded with Exosomes Promotes Diabetic Wound Healing
por: Weiyan Yuan, et al.
Publicado: (2026)

Association Between Socioeconomic Status and the Prevalence of Metabolic Diseases: A Nationwide Cross‐Sectional Study in China
por: Minghan Zhang, et al.
Publicado: (2026)

Impact of Albuminuria and Renal Dysfunction on the Anemia‐Improving Effect of SGLT2 Inhibitors in Patients With Type 2 Diabetes: A Real‐World Observational Study
por: Ayami Kajiwara-Morita, et al.
Publicado: (2025)

Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes
por: Shujun Zhang, et al.
Publicado: (2024)

Association Between Serum Advanced Glycation End Products and Cardiovascular‐Kidney‐Metabolic (CKM) Syndrome: A 3‐Year Longitudinal Cohort Study (2019–2022)
por: Hui Zhao, et al.
Publicado: (2025)

Glucose Fluctuation Inhibits Nrf2 Signaling Pathway in Hippocampal Tissues and Exacerbates Cognitive Impairment in Streptozotocin‐Induced Diabetic Rats
por: Haiyan Chi, et al.
Publicado: (2024)

Comparative disease burden of early‐onset and late‐onset type 2 diabetes in the U.S.: Evidence from NHANES 2003–2018
por: Shuoying Yue, et al.
Publicado: (2025)

Association Between Circulating Gremlin 2 and β‐Cell Function Among Participants With Prediabetes and Type 2 Diabetes
por: Mengshan Ni, et al.
Publicado: (2025)

Bioinformatics Analysis and Experimental Findings Reveal the Therapeutic Actions and Targets of Cyathulae Radix Against Type 2 Diabetes Mellitus
por: Xi Zhang, et al.
Publicado: (2024)

Diabetes Status Modifies the Association Between Cardiorespiratory Fitness and Coronary Heart Disease: A Cross‐Sectional Study
por: Li Wang, et al.
Publicado: (2025)

Association of Lifestyle‐Induced Weight Loss With Gene Expression in Subcutaneous Adipose Tissue in Metabolic Syndrome
por: Silke Zimmermann, et al.
Publicado: (2025)

Vitamin C Alleviates the Risk of Gestational Diabetes Mellitus Associated With Exposure to Metals
por: Ying Wang, et al.
Publicado: (2024)

Diabetic Retinopathy and Cognitive Dysfunction in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Epidemiological Associations and Clinical Implications
por: Ye He, et al.
Publicado: (2026)

Total Water–Soluble Flavonoids From Lithocarpus litseifolius (Hance) Chun (Sweet Tea) Improve Glucose Homeostasis Through Multitarget Signalling in GDM Mice
por: Junfei Xu, et al.
Publicado: (2024)

Impaired Cardiorespiratory Fitness in Type 1 Diabetes Is Associated With Metabolic Inflexibility and Specific Factors According to Sex
por: Liliana Muñoz‐Hernandez, et al.
Publicado: (2025)